These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 21975743)
21. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Saiz LC; Gorricho J; Garjón J; Celaya MC; Erviti J; Leache L Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010315. PubMed ID: 32905623 [TBL] [Abstract][Full Text] [Related]
22. Calcium channel blockers versus other classes of drugs for hypertension. Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L Cochrane Database Syst Rev; 2022 Jan; 1(1):CD003654. PubMed ID: 35000192 [TBL] [Abstract][Full Text] [Related]
23. Calcium channel blockers versus other classes of drugs for hypertension. Zhu J; Chen N; Zhou M; Guo J; Zhu C; Zhou J; Ma M; He L Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003654. PubMed ID: 34657281 [TBL] [Abstract][Full Text] [Related]
24. Blood pressure-lowering efficacy of reserpine for primary hypertension. Shamon SD; Perez MI Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007655. PubMed ID: 27997978 [TBL] [Abstract][Full Text] [Related]
25. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW; Laugerotte A; Wright JM Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578 [TBL] [Abstract][Full Text] [Related]
26. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease. Saiz LC; Gorricho J; Garjón J; Celaya MC; Muruzábal L; Malón MDM; Montoya R; López A Cochrane Database Syst Rev; 2017 Oct; 10(10):CD010315. PubMed ID: 29020435 [TBL] [Abstract][Full Text] [Related]
32. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis. Sun Y; Yu X; Liu J; Zhou N; Chen L; Zhao Y; Li X; Wang J; Cui L Cardiol J; 2016; 23(4):473-81. PubMed ID: 27296158 [TBL] [Abstract][Full Text] [Related]
39. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]